CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ:POZN), a pharmaceutical company focused primarily on products for the treatment of migraine, acute and chronic pain and other pain-related conditions, today announced the appointment of Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer.
